Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
about
Practical management of classical myeloproliferative disorder patients: a clinician's guideMutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiologyPulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosisPulmonary hypertension in patients with hematological disorders following splenectomy.Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series.Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities.Severe reversible pulmonary hypertension in smoldering multiple myeloma: two cases and review of the literature.Pulmonary extramedullary haematopoiesis.A critical review of anagrelide therapy in essential thrombocythemia and related disorders.Pathogenic mechanisms of pulmonary arterial hypertension.Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension.Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis.Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.Pulmonary hypertension diagnosed by echocardiography during idiopathic myelofibrosis. A case report and a brief review of the literature.Molecular genetics of myelofibrosis and its associated disease phenotypes.Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.Hematological disorders and pulmonary hypertension.Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia.Extramedullary pulmonary hematopoiesis causing pulmonary hypertension and severe tricuspid regurgitation detected by technetium-99m sulfur colloid bone marrow scan and single-photon emission computed tomography/CT.Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.Pulmonary hypertension in patients with chronic myeloproliferative neoplasms.Effectiveness of bosentan in a case of pulmonary arterial hypertension associated with myelodysplastic syndrome.Hydroxyurea-induced pneumonitis in a patient with chronic idiopathic myelofibrosis after prolonged drug exposure.Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications?Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis.Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic statusMyeloid-Derived Suppressor Cells and Pulmonary Hypertension
P2860
Q28200207-1E71B5E5-A957-460C-9639-CAB5D9F59CE4Q28218986-8B3F8CD4-A4F0-4CFE-8753-7AE16C0F54E1Q28221431-7337C7DE-6B10-4EA9-A725-8E7C21CCABA6Q33404045-2CD8BC13-784D-4454-BABB-B31519F3D748Q33738626-8E678F82-A007-4168-92C6-8936391C7DD6Q34773982-1E074114-72E1-466F-8241-940A1225FD16Q35517369-D5293A1F-6A48-4C6F-896E-68B97BA3426DQ35601791-77192E28-6CBC-4311-8BD4-33824B93C7F0Q36194626-E0D1F3E0-2CE6-4A2B-93B5-0A90E98FB8D0Q36447388-A71AE8A6-E4B1-4662-A6B6-747B4C4B6B35Q36482251-85A00164-98CC-4B19-9FA5-FEF30800325BQ37529843-9A8F8A79-9CC7-40CC-B320-4EB86DE869EFQ37565002-1D60773F-BCBF-46A7-B48E-003B6408ADDCQ38041692-35B1F823-A1B1-43BD-AF0E-29D5D8544374Q38208010-9613D530-A329-441C-96C4-5C6463E0DB2BQ38911553-FD6CCCB0-D703-4593-9BB0-579545FB098BQ39077582-88E6C8AA-2DF1-4558-8A58-5CBF567F7814Q39404090-DDCDFADF-AB83-4FB0-8E51-5687F4F776DBQ39666612-B9AF2DC8-E078-48CD-8D03-283D013EE039Q42201127-EECD159D-A4CF-4D6A-BB2F-DE6B5886A324Q44159788-A0CA9751-FA62-4E06-91E5-02F48FE8A3D4Q44680779-BCF6A891-DDE7-4046-B476-BCA97DAD2EC5Q44687562-EF44E2C8-39D9-4827-895C-2D05862F46E5Q50092007-3BA94C08-0D82-4240-8A99-6AD693056201Q53085303-34CBA036-5D94-4E22-B23D-40142ACD1628Q57488209-C87217B5-1FA4-4899-90B0-830643F6BB2AQ58800964-B8923B1A-F886-447A-900E-4CADEB371827
P2860
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@ast
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@en
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@nl
type
label
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@ast
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@en
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@nl
prefLabel
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@ast
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@en
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@nl
P2093
P356
P1433
P1476
Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
@en
P2093
P304
P356
10.1378/CHEST.120.3.801
P407
P577
2001-09-01T00:00:00Z